Q-Med says Macrolane for body augmentations approved in Europe

By E. Janene Geiss

Philadelphia, Sept. 12 - Q-Med AB said Tuesday that its product Macrolane has received a CE Mark certification for the indication concave body deformities.

Macrolane is the first product approved to be used in the field of body augmentations, for example asymmetries after liposuction.

The Uppsala, Sweden-based biotechnology company said the approval is an important step in the development of the product. Macrolane, an aesthetic treatment for the correction of body concave deformities, will now be further documented by leading plastic surgeons in the field.

The product is based on Q-Med's patented Nasha technology. The company said it continues to explore different versions of the product for other uses.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.